Charles River

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Charles River and other ETFs, options, and stocks.

About CRL

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. 

CEO
James C. Foster
CEOJames C. Foster
Employees
20,100
Employees20,100
Headquarters
Wilmington, Massachusetts
HeadquartersWilmington, Massachusetts
Founded
1947
Founded1947
Employees
20,100
Employees20,100

CRL Key Statistics

Market cap
7.99B
Market cap7.99B
Price-Earnings ratio
-104.52
Price-Earnings ratio-104.52
Dividend yield
Dividend yield
Average volume
1.38M
Average volume1.38M
High today
$164.34
High today$164.34
Low today
$160.59
Low today$160.59
Open price
$164.05
Open price$164.05
Volume
1.06M
Volume1.06M
52 Week high
$203.01
52 Week high$203.01
52 Week low
$91.86
52 Week low$91.86

Stock Snapshot

As of today, Charles River(CRL) shares are valued at $162.53. The company's market cap stands at 7.99B, with a P/E ratio of -104.52.

On 2025-11-18, Charles River(CRL) stock moved within a range of $160.59 to $164.34. With shares now at $162.53, the stock is trading +1.2% above its intraday low and -1.1% below the session's peak.

Trading activity shows a volume of 1.06M, compared to an average daily volume of 1.38M.

The stock's 52-week range extends from a low of $91.86 to a high of $203.01.

The stock's 52-week range extends from a low of $91.86 to a high of $203.01.

CRL News

TipRanks 2d
SEC Concludes Investigation on Charles River Labs

Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions AI Analyst can help you make smarter investment...

TipRanks 2d
Charles River: SEC concluded inquiry into company, not recommeding enforcement

In a regulatory filing, Charles River (CRL) said that on May 16, 2023, the company received an inquiry from the Enforcement Division of the U.S. Securities and...

Simply Wall St 6d
Did Lower Guidance and Weak Earnings Just Shift Charles River Laboratories' Investment Narrative?

On November 5, 2025, Charles River Laboratories International reported a year-over-year decrease in revenue and net income for the third quarter, alongside lowe...

Did Lower Guidance and Weak Earnings Just Shift Charles River Laboratories' Investment Narrative?

Analyst ratings

53%

of 19 ratings
Buy
52.6%
Hold
42.1%
Sell
5.3%

More CRL News

Nasdaq 6d
Wednesday Sector Leaders: Healthcare, Financial

The best performing sector as of midday Wednesday is the Healthcare sector, higher by 1.4%. Within that group, Charles River Laboratories International Inc. (Sy...

Wednesday Sector Leaders: Healthcare, Financial

People also own

Based on the portfolios of people who own CRL. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.